Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan + Cisplatin vs Etoposide + Carboplatin in Extensive Stage SCLC
NCT00812266Phase 3Terminated
- Sponsor
- Danish Oncological Lung Cancer Group
- Start
- Jan 2006
- Primary completion
- Dec 2013
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of topotecan liposome in small cell lung cancer (SCLC), sponsored by Danish Oncological Lung Cancer Group. Started Jan 2006; status: terminated.
02
Drugs
topotecan liposome
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00812266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00812266.